Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:sulfadoxine
pyrimethamine |
| gptkbp:ATCCode |
P01BD51
|
| gptkbp:contraindication |
severe renal impairment
severe liver disease sulfa allergy |
| gptkbp:discoveredIn |
1970s
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fansidar
|
| gptkbp:indication |
intermittent preventive treatment in pregnancy (IPTp)
treatment of uncomplicated malaria intermittent preventive treatment in infants (IPTi) |
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Novartis
|
| gptkbp:mechanismOfAction |
inhibits folic acid synthesis in Plasmodium
|
| gptkbp:notEffectiveAgainst |
chloroquine-resistant Plasmodium falciparum
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
gptkb:anemia
nausea vomiting rash |
| gptkbp:usedFor |
malaria
|
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:sulfadoxine-pyrimethamine
|
| gptkbp:bfsLayer |
6
|